Company / Operating Cash Flow
Genprex, Inc. Operating Cash Flow History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$24.7M
FY2024
5-year range
-$24.7M / -$2.2M
FY2020-FY2024
Trend
-40.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has declined for 5 consecutive years, from -$1M in FY2017 to -$25M in FY2024.
Based on SEC 10-K filings.
-$25M in FY2024.
Declined from -$14M to -$25M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Genprex, Inc.'s operating cash flow has declined for 5 consecutive years.
- In FY2024, operating cash flow decreased 40.4% year-over-year.
- Peak operating cash flow was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -24.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$24.7M | -40.4% |
| FY2023 | -$17.6M | -23.4% |
| FY2022 | -$14.3M | -2.5% |
| FY2021 | -$13.9M | -541.7% |
| FY2018 | -$2.2M | -74.0% |
| FY2017 | -$1.2M | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026